Perspectives for the treatment of brucellosis in the 21st century: The ioannina recommendations

被引：319

作者：

Ariza, Javier ^{[15
]}

Bosilkovski, Mile ^{[2
]}

Cascio, Antonio ^{[3
]}

Colmenero, Juan D. ^{[4
]}

Corbel, Michael J. ^{[5
]}

Falagas, Matthew E. ^{[6
,7
]}

Memish, Ziad A. ^{[8
]}

Roushan, Mohammad Reza Hasanjani ^{[9
]}

Rubinstein, Ethan ^{[10
]}

Sipsas, Nikolaos V. ^{[11
,12
]}

Solera, Javier ^{[13
]}

Young, Edward J. ^{[14
]}

Pappas, Georgios ^{[1
,16
]}

机构：

[1] Inst Continuing Med Educ Ioannina, Ioannina, Greece

[2] Ctr Clin, Clin Infect Dis & Febrile Condit, Skopje, North Macedonia

[3] Univ Messina, Dipartimento Patol Umana, Scuola Specializzaz Malattie Infett, Messina, Italy

[4] Carlos Haya Univ Hosp, Infect Dis Serv, Malaga, Spain

[5] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar, Herts, England

[6] Alfa Inst Biomed Sci, Athens, Greece

[7] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA

[8] King Fahad Natl Guard Hosp, Dept Infect Prevent & Control, Riyadh, Saudi Arabia

[9] Babol Univ Med Sci, Yahyanejad Hosp, Dept Infect Dis, Babol Sar, Iran

[10] Univ Manitoba, Infect Dis Sect, Winnipeg, MB, Canada

[11] Natl & Kapodistrian Univ Athens, Laikon Gen Hosp, Dept Pathophysiol, Athens, Greece

[12] Natl & Kapodistrian Univ Athens, Sch Med, Dept Pathophysiol, Athens, Greece

[13] Hosp Gen Univ, Med Interna Serv, Albacete, Spain

[14] Vet Affairs Med Ctr, Med Serv, Houston, TX 77030 USA

[15] Univ Barcelona, Bellvitge Hosp, Serv Enfermedades Infecciosas, Barcelona, Spain

[16] Int Soc Chemotherapy, Working Grp Zoonoses, London, England

来源：

PLOS MEDICINE | 2007年 / 4卷 / 12期

关键词：

D O I：

10.1371/journal.pmed.0040317

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

页码：1872 / 1878

页数：7

共 61 条

[1]

Al-Hajjaj M S, 2001, Respirology, V6, P317, DOI 10.1046/j.1440-1843.2001.00344.x

[2]

SKELETAL BRUCELLOSIS IN IRAQI PATIENTS [J].

ALRAWI, TI ;

THEWAINI, AJ ;

SHAWKET, AR ;

AHMED, GM .

ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (01) :77-79

[3]

ALRAWI ZS, 1987, BRIT J RHEUMATOL, V26, P24

[4]

ALVAREZ S, 1982, REV INFECT DIS, V4, P390

[5]

[Anonymous], 1986, World Health Organ Tech Rep Ser, V740, P1

[6]

ARIZA J, 1985, REV INFECT DIS, V7, P656

[7]

COMPARATIVE TRIAL OF CO-TRIMOXAZOLE VERSUS TETRACYCLINE-STREPTOMYCIN IN TREATING HUMAN BRUCELLOSIS [J].

ARIZA, J ;

GUDIOL, F ;

PALLARES, R ;

RUFI, G ;

FERNANDEZVILADRICH, P .

JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06) :1358-1359

[8]

Brucellosis at the XXIst century [J].

Ariza, J .

MEDICINA CLINICA, 2002, 119 (09) :339-344

[9]

CHARACTERISTICS OF AND RISK-FACTORS FOR RELAPSE OF BRUCELLOSIS IN HUMANS [J].

ARIZA, J ;

CORREDOIRA, J ;

PALLARES, R ;

VILADRICH, PF ;

RUFI, G ;

PUJOL, M ;

GUDIOL, F .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1241-1249

[10]

TREATMENT OF HUMAN BRUCELLOSIS WITH DOXYCYCLINE PLUS RIFAMPIN OR DOXYCYCLINE PLUS STREPTOMYCIN - A RANDOMIZED, DOUBLE-BLIND-STUDY [J].

ARIZA, J ;

GUDIOL, F ;

PALLARES, R ;

VILADRICH, PF ;

RUFI, G ;

CORREDOIRA, J ;

MIRAVITLLES, MR .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) :25-30

← 1 2 3 4 5 6 7 →